arXiv Computer Vision By Manon Dausort, Tiffanie Godelaine, Karim El Khoury, Maxime Zanella, Christophe De Vleeschouwer, Beno\^it Macq

Refining Cytology Predictions with Conditional Random Fields

Read the original on arXiv Computer Vision →

The paper introduces CytoCRF, a conditional random field framework tailored for cytology images. It adapts pairwise terms to focus on chromatin and cytology-specific staining and enriches neighborhood information by combining multiple backbone models. Across ten cytology datasets, CytoCRF surpasses existing CRF methods at all annotation budgets, achieving up to +13.6 percentage points over the best baseline and +33.7 over zero‑shot performance with only 50 annotations.

Machine-generated by The Flow from the publisher's headline and feed description — not written or checked by a human. The full article lives at arXiv Computer Vision.

arXiv Machine Learning
Aug 12

Retrieval-Augmented Vision Foundation Models for Robust Leukemia Cell Classification across Multiple Microscopy Datasets

arXiv:2608. 10657v1 Announce Type: cross Abstract: Leukemia cell image classification is challenged by real-world domain shifts from acquisition, staining, illumination, and site protocols, causing single-dataset models to generalize poorly in real clinical scenarios.

By Carlos Zamora, Hiram Zuniga, Ulises Orozco-Rosas, Kenia Picos
arXiv AI
Jul 3

Towards Cellular-Scale Interpretability in Pathology Foundation Models for Biomarker Assessment

arXiv:2511. 05150v2 Announce Type: replace-cross Abstract: Molecular biomarker testing in pathology is often costly and tissue-consuming, limiting scalable clinical deployment.

By Jingsong Liu, Han Li, Zhengyang Xu, Franz-Leonard Klaus, Fabian St\"ogbauer, Shihui Zu, Weiwei Zhou, Atsuko Kasajima, Felix Schicktanz, Alexander Muckenhuber, Julius Shakhtour, Jiale Yu, Tiannan Zheng, Xun Ma, Maggie Wang, Christian Grashei, Bao Li, Guiyang Jiang, Hongming Xu, Shaohua Kevin Zhou, Nassir Navab, Peter J. Sch\"uffler
arXiv Computer Vision
4d ago

HERO: Histology Encoder for Robust Representation in Oncology

HERO (Histology Encoder for Robust Representation in Oncology) is a ViT‑G/14 pathology foundation model trained with DINO and iBOT objectives and refined using high‑resolution Gram anchoring on a 500‑million‑tile corpus from about 575,000 clinical whole‑slide images. It demonstrates superior robustness to center, scanner, and stain variation compared to other state‑of‑the‑art foundation models, while maintaining competitive performance on tile‑level classification, segmentation, and gene‑expression prediction. Across 39 slide‑level clinical tasks, HERO ranks first on average and achieves the best average rank across six benchmark frameworks under an equal‑weighted analysis.

By Zhi Li (Caris Life Sciences, Irving, TX, United States), Eghbal Amidi (Caris Life Sciences, Irving, TX, United States), Yating Cheng (Caris Life Sciences, Irving, TX, United States), Tyson Dawson (Caris Life Sciences, Irving, TX, United States), Gorkem Can Ates (Caris Life Sciences, Irving, TX, United States), Shuzhen Kuang (Caris Life Sciences, Irving, TX, United States), Norsang Lama (Caris Life Sciences, Irving, TX, United States), Md Ashequr Rahman (Caris Life Sciences, Irving, TX, United States), Zhiying Lu (Caris Life Sciences, Irving, TX, United States), Elisabeth K. Kong (Caris Life Sciences, Irving, TX, United States), Milan Radovich (Caris Life Sciences, Irving, TX, United States), David Spetzler (Caris Life Sciences, Irving, TX, United States), Matthew Oberley (Caris Life Sciences, Irving, TX, United States), George W. Sledge (Caris Life Sciences, Irving, TX, United States), Ming Chen (Caris Life Sciences, Irving, TX, United States)